Part of an enterprise-wide commitment to the fight against cancer, Phoenix Children’s Hospital now covers the GPS Cancer test as an in-network benefit to employees and dependents covered under the Phoenix Children’s health plan. GPS Cancer, created by NantHealth, integrates whole genome (DNA) sequencing, whole transcriptome (RNA) sequencing, and quantitative proteomics to provide oncologists with a detailed molecular profile of a patient’s cancer. Evaluating a comprehensive molecular profile of a patient’s cancer informs personalized treatment strategies, ultimately reducing the amount of guesswork and optimizing patient care.
Offering GPS Cancer as a covered benefit is part of Phoenix Children’s larger mission to harness the power of precision medicine and improve outcomes for patients battling cancer. Phoenix Children’s is the leading partner in the Pediatric Consortium of Cancer Moonshot 2020, and its Center for Cancer and Blood Disorders is nationally ranked among U.S. News & World Report’s Best Children’s Hospital.